Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
JACS Au|August 1, 2022
Chemical Synthesis and Immunological Evaluation of Fragments of the Multiantennary Group-Specific Polysaccharide of Group B StreptococcusZhen Wang, Jacopo Enotarpi, Giada Buffi, et al.
Chemical Science|March 21, 2022
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidatesFilippo Carboni, Annabel Kitowski, Charlotte Sorieul, et al.
Carbohydrate Polymers|June 14, 2024
Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine designGian Pietro Pietri, Sara Bertuzzi, Katarina Karnicar, et al.
Journal of the American Chemical Society|January 10, 2025
Long, Synthetic Staphylococcus aureus Type 8 Capsular Oligosaccharides Reveal Structural Epitopes for Effective Immune RecognitionKitt Emilie Østerlid, Charlotte Sorieul, Luca Unione, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2025
Synthesis, Conformal Analysis, and Antibody Binding of Staphylococcus aureus Capsular Polysaccharide Type 5 OligosaccharidesKitt E Østerlid, Sizhe Li, Luca Unione, et al.
Frontiers in Molecular Biosciences|November 1, 2021
Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular PolysaccharideGian Pietro Pietri, Marta Tontini, Barbara Brogioni, et al.
Nature Communications|November 26, 2020
Publisher Correction: A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Nature Communications|September 8, 2020
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
NPJ Vaccines|October 6, 2023
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particlesFilippo Carboni, Roberta Cozzi, Giacomo Romagnoli, et al.
Pageof 7